EDN1 and neoplasm: The engagement of ETAR by ET-1 triggers the activation of tumor proliferation [10-14], vascular endothelial growth factor (VEGF)-induced angiogenesis [15,16], invasiveness [17], and the inhibition of apoptosis [18,19].